TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05947968

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular PNF
Description: Scapular proprioceptive neuromuscular facilitation exercise: will be applied in two diagonals:~1. anterior elevation and posterior depression~2. posterior elevation and anterior depression for 3 sets of 10 repetitions, The rest interval between sets will be 20 seconds.~Patients will lay on the unaffected side while the therapist stands in the line of desired motion. Firstly, the therapist will give preparatory instructions. In the beginning of the pattern, the therapist pulls the scapula to the elongated position and then gives instructions for the desired movement.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shoulder strengthening exercises
Description: Shoulder strengthening exercises:~The following four exercises will focus on shoulder and scapular strengthening. Before starting the program, the patients will be thoroughly instructed in the four exercises, and illustrations with specific exercise instructions will be provided. All subjects will perform the exercises with the affected side for three sets of 10 repetitions for each exercise, with a 1-minute rest between sets.~1. Standing shoulder external rotation with elastic resistance.~2. Bilateral external rotation with scapular retraction exercise.~3. Resisted scapular retraction with shoulder external rotation (Middle trapezius muscle).~4. Weighted scapular retraction and downward rotation Y-shape (lower trapezius muscle).
Study: NCT04852484

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: local anesthetic-morphine
Description: Before the operation, 19 mL of 0.5% Ropivacaine + 2 mg of morphine (20 mL in total) will be injected in the paravertebral space. Afterwards, there will be a pump of 500 ml of 0.2 % ropivacaine + 6 mg of morphine connected to the catheter after the end of the surgery, administered continuously at a rate of 10 mL/hr

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: local anesthetic-ketamine
Description: Before the operation, 19 mL of 0.5% Ropivacaine + 50 mg of ketamine (20 mL in total) will be injected in the paravertebral space. Afterwards, there will be a pump of 500 ml of 0.2 % ropivacaine + 200 mg of ketamine connected to the catheter after the end of the surgery, administered continuously at a rate of 10 mL/hr

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: local anesthetic
Description: Before the operation, 19 mL of 0.5% Ropivacaine + 1 mL of normal saline (20 mL in total) will be injected in the paravertebral space. Afterwards, there will be a pump of 500 ml of 0.2 % ropivacaine connected to the catheter after the end of the surgery, administered continuously at a rate of 10 mL/hr
Study: NCT04253652

Intervention type: OTHER
Intervention: Fasted breath samples
Description: Will be completed pre and post iron therapy

Intervention type: OTHER
Intervention: Fasted breath samples
Description: Will be completed pre and post iron therapy

Intervention type: OTHER
Intervention: IBS-SSS
Description: Will be completed pre and post iron therapy

Intervention type: OTHER
Intervention: IBS-SSS
Description: Will be completed pre and post iron therapy

Intervention type: OTHER
Intervention: Daily diary
Description: Monitoring stool form, consistency and frequency on a daily basis for 4 weeks

Intervention type: OTHER
Intervention: Daily diary
Description: Monitoring stool form, consistency and frequency on a daily basis for 4 weeks

Intervention type: OTHER
Intervention: Exploratory research: stool samples
Description: Completed pre and post iron therapy for a subset of patients enrolled in the study

Intervention type: OTHER
Intervention: Exploratory research: stool samples
Description: Completed pre and post iron therapy for a subset of patients enrolled in the study
Study: NCT06106399

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: WALLANT
Description: Comparison between (WALLANT) and (CPB) as a sole anesthesia in clavicle surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: WALLANT
Description: Comparison between (WALLANT) and (CPB) as a sole anesthesia in clavicle surgery
Study: NCT05223374

Intervention type: DEVICE
Intervention: Canvas Dx
Description: Canvas Dx is intended for use by healthcare providers as an aid in the diagnosis of autism spectrum disorder (ASD) for patients ages 18 months through 72 months who are at risk for developmental delay based on concerns of a parent, caregiver, or healthcare provider. The device is not intended for use as a stand-alone diagnostic device but as an adjunct to the diagnostic process. The device is for prescription use only (Rx only)
Study: NCT06313242

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene Glycol Electrolytes Powder (II)
Description: Polyethylene Glycol Electrolytes Powder (II) was used for bowel preparation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low residue diet
Description: Low residue diet 1 day before the test, fasting from 20:00 pm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normal diet
Description: Normal diet 1 day before the test, fasting from 20:00 pm.
Study: NCT04576962

Intervention type: OTHER
Intervention: Immunization Information System Review
Description: Extraction of county- and state-level data on HPV vaccine completion from Indiana's Immunization Information System
Study: NCT06596694

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Patritumab deruxtecan
Description: Administered via intravenous (IV) infusion
Study: NCT05585515

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Description: Total sleep deficit of consecutive 8 hours

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep restriction
Description: Total sleep deficit of cumulative 8 hours
Study: NCT05869500

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Left Bundle Branch Area Pacemaker
Description: Implantation of Medtronic 3830 lead for left bundle branch area pacing

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Right Ventricular Pacemaker
Description: Implantation of a conventional right ventricular pacemaker lead
Study: NCT04966000

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prism Adaptation Therapy
Description: Participants wear goggles with built-in prisms (a 20-diopter lens) that shift the visual scene to the right. While wearing the googles they reach to and cross out 60 lines/circles, requiring them to learn to reach more leftward than the visual targets appear. Participants can only see the end of their movements.
Study: NCT04660721

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: sFilm-FS
Description: sFilm-FS is a sterile bio-compatible bio-absorbable patch embedded with lyophilized powders of Human Fibrinogen, Human Thrombin and calcium chloride.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: TACHOSIL®
Description: TACHOSIL® is a fibrin sealant patch composed of an equine collagen patch coated with Human Fibrinogen and Human Thrombin.
Study: NCT05489900

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine Hydrochloride
Description: Dexmedetomidine is a specific and potent α2-adrenergic agonist. By acting directly on the sympathetic nervous system, they can exert beneficial effects on the immune system through neuroimmune interactions. Its administration can induce an anti-inflammatory response due to different central (increase parasympathetic tone, promoting control of the inflammatory condition) and peripheral effects (stimulating innate immunity).(MILLER, 2015).~Venous blood samples were collected at three times (T1, T2 and T3): Before anesthetic induction with collection in the preoperative environment on the day of surgery or during venoclysis before anesthetic induction (sample 1, T1); 6 hours after starting orifice closure and completion of drug or placebo infusion (sample 2, T2); and the last blood sample will be collected by me on the morning after the postoperative period, close to hospital discharge - 24h (sample 3, T3).
Study: NCT06262256

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: supervised exercise conducted on stationary bikes after individualized intensity prescription.
Study: NCT05202821

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRG Barrier Coat
Description: 3 arm randomized single blind clinical trial comparing 3 groups. first group will be receiving fluoride varnish, second group will be receiving PRG Barrier Coat and the third group will be receiving MI paste

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride varnish
Description: First group will be receiving Fluoride varnish every 3 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MI paste
Description: Third group will be receiving MI paste
Study: NCT05558566

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurofeedback from the SMA
Description: Feedback is provided regarding activity in the SMA and participant attempts to control SMA activity using the feedback as a training signal

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurofeedback from control region
Description: Feedback is provided regarding activity in a control region and participant attempts to control activity in that region using the feedback as a training signal.
Study: NCT06463522

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous Tumor-infiltrating Lymphocytes
Description: Autologous Tumor-infiltrating Lymphocytes, 2.0\*10\^7/Kg, single intravenous infusion.
Study: NCT05217420

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moving Well
Description: Experimental arm

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Staying Well
Description: Active comparator arm
Study: NCT05135520

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transvaginal natural orifice specimen extraction (NOSE)
Description: Under general anesthesia, patients who are planned to perform multiport laparoscopic surgery for resection of solid organs including kidney or bladder will undergo Transvaginal NOSE

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transabdominal specimen extraction
Description: Under general anesthesia, patients who are planned to perform multiport laparoscopic surgery for resection of solid organs including kidney or bladder will undergo transabdominal specimen extraction with incision elongation
Study: NCT06022120

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: An integrated health literacy intervention
Description: The intervention investigates the effect of the Australian WorkHealth Improvement Network (WIN) program and the Total Worker Health (TWH) concepts in a Danish contexts among students at risk of poorer health outcomes compared to their peers with stronger literacy skills.
Study: NCT05506852

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based training strategy
Description: Participants will undergo a web-based training protocol where they will play an online game that simulates a breakfast environment and will perform everyday activities as cooking and setting tables in a multi-tasking fashion. Participants will learn to play the game using specific strategies, in order to optimize the performance.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web-based regular training (no strategy)
Description: Participants will undergo a web-based training protocol where they will play an online game that simulates a breakfast environment and will perform everyday activities as cooking and setting tables in a multi-tasking fashion. Participants will learn to play the game under regular game instructions.
Study: NCT05982509

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EasyDew Regen MD Cream
Description: For the study group, I received the prescription Easy Dew Regen MD Cream from Picosure Laser Apply an appropriate amount twice a day (morning and evening) to the skin of the area so that it can be absorbed well do. The control group is the non-chalant group. However, for one month after the procedure, it is not a medical device The normal moisturizer you use at home is available, and the area where you have undergone laser treatment Apply it twice a day (morning and evening) to the skin so that it can be absorbed well.
Study: NCT06269497

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaffold placement
Description: The scaffold is placed in the alveola following extraction

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: CBCT
Description: A Cone Beam Computer Tomography (CBCT) is taken of the area of interest after surgery
Study: NCT05414825

Intervention type: OTHER
Intervention: focus group interview
Description: Group interview gathering words, views, symptoms and its repercussions, and main issues of the subjects regarding severe dysmenorrhea

Intervention type: OTHER
Intervention: focus group interview
Description: Group interview gathering words, views, symptoms and its repercussions, and main issues of the subjects regarding severe dysmenorrhea
Study: NCT04390217

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB1148
Description: LB1148 is delivered orally/enterally, 700 mL per day split into two administrations of 350 mL, approximately 12 hours apart, for up to 7 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is delivered orally/enterally, 700 mL per day split into two administrations of 350 mL, approximately 12 hours apart, for up to 7 days.
Study: NCT06271252

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OriCAR-017
Description: Anti-GPRC5D CAR-T cell product
Study: NCT05414825

Intervention type: OTHER
Intervention: focus group interview
Description: Group interview gathering words, views, symptoms and its repercussions, and main issues of the subjects regarding severe dysmenorrhea

Intervention type: OTHER
Intervention: focus group interview
Description: Group interview gathering words, views, symptoms and its repercussions, and main issues of the subjects regarding severe dysmenorrhea

Intervention type: OTHER
Intervention: focus group interview
Description: Group interview gathering words, views, symptoms and its repercussions, and main issues of the subjects regarding severe dysmenorrhea
Study: NCT05038202

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bencycloquidium Bromide Nasal Spray
Description: The content of this product is a colorless and clear liquid, press the sprayer, the liquid will be sprayed out in mist.~This product is suitable for improving the symptoms of runny nose, nasal congestion, nasal itching and sneezing caused by allergic rhinitis.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bencycloquidium Bromide Nasal Spray
Description: The content of this product is a colorless and clear liquid, press the sprayer, the liquid will be sprayed out in mist.~This product is suitable for improving the symptoms of runny nose, nasal congestion, nasal itching and sneezing caused by allergic rhinitis.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mometasone Furoate Aqueous Nasal Spray
Description: Mometasone furoate nasal spray is a quantitative hand-press spray device, and the content is a white to off-white suspension.~This product is suitable for the treatment of seasonal or perennial rhinitis in adults, adolescents and children from 3 to 11 years old. For patients who have had moderate to severe seasonal allergic rhinitis symptoms, it is recommended to use this product 2-4 weeks before the start of the pollen season Preventive treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone Furoate Aqueous Nasal Spray
Description: Mometasone furoate nasal spray is a quantitative hand-press spray device, and the content is a white to off-white suspension.~This product is suitable for the treatment of seasonal or perennial rhinitis in adults, adolescents and children from 3 to 11 years old. For patients who have had moderate to severe seasonal allergic rhinitis symptoms, it is recommended to use this product 2-4 weeks before the start of the pollen season Preventive treatment.
Study: NCT05485025

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai chi training
Description: Tai chi, also called tai chi chuan, is an ancient Chinese form of exercise originally created as a fighting art. It is a kind of gentle physical exercise and stretching, which involves a series of movements performed in a slow, focused manner and accompanied by deep breathing.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group activity
Description: A organizer will lead the subjects to participate in group activities once a quarter. In group activities, there will be popular science lectures and interactive games.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group activity
Description: A organizer will lead the subjects to participate in group activities once a quarter. In group activities, there will be popular science lectures and interactive games.
Study: NCT05484297

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Crisis Caring Contacts post cards
Description: A series of post cards with Crisis Caring Contacts content sent over 10 months

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control post cards
Description: A series of post cards intended to control for attention received but not including elements thought to be active ingredients in the intervention
Study: NCT05058157

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: different ketogenic formulae
Description: The research product may be in a form of powder to reconstitute or in a ready-to-drink format.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: different ketogenic formulae
Description: The research product may be in a form of powder to reconstitute or in a ready-to-drink format.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: different ketogenic formulae
Description: The research product may be in a form of powder to reconstitute or in a ready-to-drink format.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: different ketogenic formulae
Description: The research product may be in a form of powder to reconstitute or in a ready-to-drink format.
Study: NCT06145269

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: New oral anticoagulant (rivaroxaban) and Marevan (warfarin)
Description: comparison between 2 drug, (rivaroxaban) and Marevan (warfarin)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: New oral anticoagulant (rivaroxaban) and Marevan (warfarin)
Description: comparison between 2 drug, (rivaroxaban) and Marevan (warfarin)
Study: NCT06673745

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IASTM
Description: Group A received IASTM treatment, which will be given by the Edge tool, that is an ergonomically designed stainless steel instrument and offers several different hand holds, eliminating operator fatigue. Prior to the treatment, the IASTM therapeutic effects will be explained. The scanning assessment will be done to identify areas of restrictions directed by the gritty sensations using the Edge tool. Each restriction will be treated with the tool for 30-60 sec and given. This treatment will be given for 30 minutes for 3 days per week for 4 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic cupping therapy
Description: On the contrary, group B the patient will be seated in a chair with the elbow flexed on the plinth to relax the forearm muscles. The area around the elbow joint will be cleaned with alcohol to remove any foreign bodies from the treated area. Dynamic cupping therapy for elbow stiffness will begin with an assessment of the patient\&amp;#39;s condition, where factors such as the extent of stiffness and range of motion in the elbow joint will be evaluated. Following this assessment, lubricant will be applied to the skin surrounding the elbow to facilitate smooth movement of the cups. Cups of suitable size and material will then be strategically placed around the elbow joint, and suction will be created inside each cup to create a vacuum effect. Once thesecurely attached, the practitioner will move them around the elbow area using gentle techniques such as gliding or pumping motions.
Study: NCT05223478

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phentolamine Ophthalmic Solution 0.75%
Description: 0.75% phentolamine ophthalmic solution (Nyxol), a non-selective alpha-1 and alpha-2 adrenergic antagonist

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Phentolamine Ophthalmic Solution Vehicle
Description: Phentolamine Ophthalmic Solution Vehicle
Study: NCT05490849

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-HX01
Description: For pharmacokinetics, healthy volunteer underwent 68Ga-HX01 PET imaging. Blood samples were collected at 25 min, 55 min, and 115 min after imaging agent injection, and urine specimens were collected at 28 min, 58 min, and 118 min after injection to measure radioactivity in blood and urine. PET/MR scans were performed at 30-50 min, 60-80 min, and 120-140 min after injection to understand absorption, distribution, and metabolism.~Cancer patients,~1. Subjects should have 68Ga-HX01 and 18F-FDG PET scans two days apart.~2. Blood tests, liver and kidney function, tumor markers (CA125, CA199, CEA, etc.), and other biochemical markers must be performed one week prior to and after imaging.~3. Tumor biopsies or surgical specimens should be evaluated histopathologically and immunostained for biomarkers associated with angiogenesis.
Study: NCT06380959

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Art Based Activity
Description: Art Based Activity Module consists of 3 art-based activities under the titles My Life Journey, The Power Within Me and Letter to the Future. Each activity consists of three stages. In the first stage, the participants were made to practice breathing exercises. At this stage, the participant was expected to become aware of himself and his ideas. In the second stage, art activity was carried out. In the final stage, the revealed art object was concretized by the participants with a verbal expression. The materials used in the activities (dry paint, pastel paint, watercolor) are dermatologically tested and consist of anti-allergen products.
Study: NCT06268561

Intervention type: OTHER
Intervention: Visual acuity analysis
Description: Collection of information on visual acuity from the medical file concerning the surgery

Intervention type: OTHER
Intervention: Intraocular pressure analysis
Description: Collection of information on intraocular pressure from the medical file concerning the surgery

Intervention type: OTHER
Intervention: Analysis of optical coherence tomography (OCT) images
Description: Collection and analysis of optical coherence tomography (OCT) images of the medical file concerning the surgery
Study: NCT04850092

Intervention type: OTHER
Intervention: Positional change from supine to prone
Description: Patient is turned from supine to prone position for spine surgery

Intervention type: OTHER
Intervention: Positional change from supine to prone
Description: Patient is turned from supine to prone position for spine surgery
Study: NCT03989778

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Vitamin D supplementation